key: cord-0914491-7vd6kww3
authors: Quak, Elske; Morel, Adeline; Faudemer, Julie; Levy, Christelle; Ciappuccini, Renaud
title: Subdiaphragmatic Lymph Nodes Uptake on (18)F-FDG PET/CT After COVID-19 Vaccination in the Thigh
date: 2021-10-19
journal: Clin Nucl Med
DOI: 10.1097/rlu.0000000000003941
sha: dac4149e6d1a8965297e4c3284d5b770bd23dba9
doc_id: 914491
cord_uid: 7vd6kww3

Since worldwide COVID-19 vaccination, (18)F-FDG uptake in reactive axillary lymph nodes has been frequently observed in PET/CT studies. We describe a patient with breast cancer who underwent (18)F-FDG PET/CT 7 days after receiving COVID-19 vaccination in the right thigh. (18)F-FDG uptake was observed in nonenlarged right-sided inguinal, iliac, and para-aortic lymph nodes. As the thigh can be used as an alternate site for COVID-19 vaccine injection in case of lymphedema in both arms or for adequate axillary staging in patients with breast cancer, physicians should be aware of such (18)F-FDG uptake pattern.

Since the launch of large-scale COVID-19 vaccination, 18 F-FDG uptake in reactive axillary lymph nodes (LNs) is frequently observed in PET/CT studies. 1-7 A 74-year-old woman underwent 18 F-FDG PET/CT for staging of left breast cancer 2 weeks after receiving the first dose of the Oxford-AstraZeneca COVID-19 vaccination in the right arm. 18 F-FDG PET/CT showed high uptake in the primary tumor (A, black arrow) without signs of LN or distant metastasis and moderate LN uptake in the right axilla related to vaccination (A, red arrow). After 3 cycles of neoadjuvant chemotherapy and 7 days after repeat Pfizer-BioNTech COVID-19 vaccine in the right thigh, she underwent 18 F-FDG-PET/CT for response evaluation. Complete metabolic response was observed for the primary tumor, but 18 F-FDG uptake was observed in nonenlarged right-sided inguinal, iliac, and para-aortic LNs related to the vaccination in the thigh (B-E, red arrows). In patients who previously received COVID-19 vaccine in the deltoid muscle, PET/CT studies can show 18 F-FDG-positive LNs in the ipsilateral axilla that should not be mistaken for cancer, highlighting the need for the nuclear medicine physician to check timing and side of prior vaccination. The thigh can be used as an alternate injection site, for example in case of lymphedema in both arms. 8 COVID-19 vaccination in the thigh might also be an option for adequate axillary staging in patients with breast cancer. 9,10 Physicians should be aware of the previously described 18 F-FDG uptake pattern in the subdiaphragmatic LN chains that vaccination in the thigh may provoke.

The challenge of staging breast cancer with PET/CT in the era of COVID vaccination

Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA COVID-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation

COVID-19 vaccine-related local FDG uptake

FDG PET findings post-COVID vaccinations: signs of the times?

False-positive axillary lymph nodes on FDG PET/CT resulting from COVID-19 immunization

18 F-FDG-avid lymph nodes after COVID-19 vaccination on 18 F-FDG PET/CT

COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET/CT

The National Cancer Institute. Coronavirus vaccines and people with cancer: a Q&A with Dr

Mitigating the impact of coronavirus disease (COVID-19) vaccinations on patients undergoing breast imaging examinations: a pragmatic approach

Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties